🇺🇸 FDA
Patent

US 9340522

Pyrazolone-derivatives and their use as PDE-4 inhibitors

granted A61PA61P11/00A61P11/02

Quick answer

US patent 9340522 (Pyrazolone-derivatives and their use as PDE-4 inhibitors) held by TAKEDA GMBH expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/06, A61P11/08